Inventors with similar research interests:
Location History:
- Harlow, GB (1997)
- Cambridge, GB (1993 - 1998)
- Essex, GB (1998)
- Duxford, GB (1990 - 2008)
Company Filing History:
53 out of 2,405 
1 out of 1 
1 out of 1 
Years Active: 1990-2008
Title: Christopher John Swain: A Prolific Innovator in Pharmacology
Introduction:
Christopher John Swain, hailing from Duxford, GB, is a prominent figure in the field of pharmacology and drug discovery. With an impressive portfolio of 53 patents to his name, Swain has consistently demonstrated his expertise and dedication to advancing the medical sciences. This article provides an overview of his latest patents, career highlights, collaborations, and his significant contributions to the pharmaceutical industry.
Latest Patents:
Swain's recent patents reflect his keen focus on developing therapeutic agents for various medical conditions. Two noteworthy patents are:
1. Tetrahydropyran compounds as tachykinin antagonists:
These compounds, as depicted by the formula (Ia), demonstrate potential in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis, and postherpetic neuralgia. Swain's invention contributes to the ever-growing arsenal of medication aimed at combating these prevalent health issues.
2. Gem-disubstituted cyclohexane derivatives as therapeutic agents:
The compounds described in this patent (formula I) present promising prospects for treating depression, anxiety, pain, inflammation, migraine, emesis, and postherpetic neuralgia. Swain's ingenuity in identifying and optimizing these compounds showcases his commitment to improving patient care and quality of life.
Career Highlights:
Swain has made remarkable contributions to the field of pharmacology during his tenure at renowned companies like Merck Sharp & Dohme Corporation and Merck Sharp. His innovative mindset and expertise have led him to develop a comprehensive patent portfolio encompassing a diverse range of therapeutic areas.
Collaborations:
Swain's professional journey has been enriched by collaboration with esteemed colleagues. Notably, he has worked closely with Raymond Baker and Brian John Williams, who have played significant roles in his research and development endeavors. Their combined efforts exemplify the power of collaboration in driving scientific progress and the emergence of groundbreaking inventions.
Conclusion:
With an enviable track record of 53 patents, Christopher John Swain has established himself as a leading innovator in the pharmaceutical industry. Through his invention of novel compounds, he has contributed to addressing crucial medical challenges, ranging from depression and anxiety to pain and inflammation. Swain's collaborative spirit and exceptional career highlights emphasize the importance of teamwork in fostering advancements in the field of pharmacology. His dedication to developing therapeutic agents that enhance patient well-being solidifies his position as a remarkable figure in the realm of innovations and patents.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.